Black Diamond Therapeutics, Inc. (BDTX)

BDTX Statistics

Total Valuation

BDTX has a market cap or net worth of $124.49 million. The enterprise value is $34.80 million.

Market Cap	124.49M
Enterprise Value	34.80M

Important Dates

The next estimated earnings date is Tuesday, March 11, 2025, before market open.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

BDTX has 56.59 million shares outstanding. The number of shares has increased by 34.09% in one year.

Current Share Class	56.59M
Shares Outstanding	56.59M
Shares Change (YoY)	+34.09%
Shares Change (QoQ)	+2.45%
Owned by Insiders (%)	2.29%
Owned by Institutions (%)	69.60%
Float	39.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.28
P/TBV Ratio	1.28
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.55, with a Debt / Equity ratio of 0.24.

Current Ratio	5.55
Quick Ratio	5.42
Debt / Equity	0.24
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -63.09% and return on invested capital (ROIC) is -36.22%.

Return on Equity (ROE)	-63.09%
Return on Assets (ROA)	-32.78%
Return on Capital (ROIC)	-36.22%
Revenue Per Employee	n/a
Profits Per Employee	-$1.35M
Employee Count	54
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.99% in the last 52 weeks. The beta is 2.50, so BDTX's price volatility has been higher than the market average.

Beta (5Y)	2.50
52-Week Price Change	-21.99%
50-Day Moving Average	2.49
200-Day Moving Average	4.42
Relative Strength Index (RSI)	46.41
Average Volume (20 Days)	1,187,212

Short Selling Information

The latest short interest is 6.36 million, so 11.24% of the outstanding shares have been sold short.

Short Interest	6.36M
Short Previous Month	6.40M
Short % of Shares Out	11.24%
Short % of Float	16.06%
Short Ratio (days to cover)	13.03

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-81.36M
Pretax Income	-80.55M
Net Income	-73.10M
EBITDA	-81.02M
EBIT	-81.36M
Earnings Per Share (EPS)	-$1.36

Balance Sheet

The company has $112.68 million in cash and $23.00 million in debt, giving a net cash position of $89.68 million or $1.58 per share.

Cash & Cash Equivalents	112.68M
Total Debt	23.00M
Net Cash	89.68M
Net Cash Per Share	$1.58
Equity (Book Value)	97.43M
Book Value Per Share	1.72
Working Capital	94.74M

Cash Flow

Operating Cash Flow	-61.20M
Capital Expenditures	n/a
Free Cash Flow	-61.20M
FCF Per Share	-$1.08

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BDTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.09%
Shareholder Yield	-34.09%
Earnings Yield	-58.72%
FCF Yield	-49.16%

Analyst Forecast

The average price target for BDTX is $15.50, which is 604.55% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.50
Price Target Difference	604.55%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1